Polypeptide active pollen immunosuppressant fraction

Details Polypeptide active pollen immunosuppressant fraction Polypeptide active pollen immunosuppressant fraction

1980-04-14

1982-07-06

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

260112R, A61K 3936, C07G 700

Patent

active

043382975

ABSTRACT:
Polypeptide active pollen immunosuppressant prepared by proteolytic enzyme digestion of pollen antigen and purified by reaction with antipollen antibody and therapeutic use thereof in desensitization.

REFERENCES:
Chemical Abstracts, vol. 81, p. 181, 1974, Abst. No. 2173e, "Chemical Modification of the Major Allergen of Ragweed Pollen, Antigen E".
Chemical Abstracts, vol. 82, p. 439, 1975, Abst. No. 55957r, "Immunogenic Properties of Modified Antigen E. II. Ability of Urea-Denatured Antigen and .alpha.-Polypeptide Chain".
Chemical Abstracts, vol. 83, p. 297, 1975, Abst. No. 191261g, "Immunogenic Properties of Modified Antigen E. III. Effect of Repeated Injections of Modified Antigen".
Takatsu, K., et al., J. Immunology, vol. 115, pp. 1469-1476, 1975.
King, T., et al., Immunochemistry, vol. 11, pp. 83-92, 1974.

Affiliated with

Also associated with

Rating

Polypeptide active pollen immunosuppressant fraction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptide active pollen immunosuppressant fraction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide active pollen immunosuppressant fraction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2168261